Overview Financials News + Filings Key Docs Charts Insiders
|
|
RBC LIFE SCIENCES, INC. (RBCL)
|
Add to portfolio |
|
|
|
| Price: |
$0.23
| | Metrics |
| OS: |
2.21
|
M
| |
-7
|
% ROE
|
| Market cap: |
$508.8
|
k
| |
-12
|
% ROIC
|
|
Net cash:
|
$2.09
|
M
| |
$0.95
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($87.3)
|
k
| |
|
|
|
EBIT
|
($608.1)
|
k
| |
|
|
| EPS |
($0.25)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| Revenues | 28.3 | 25.5 | 25.2 | 28.4 | 28.2 | 24.9 | 30.4 | 27.0 |
| Revenue growth | 11.0% | 1.2% | -11.6% | 1.0% | 13.0% | -18.0% | 12.5% | 24.6% |
| Cost of goods sold | 12.6 | 13.5 | 12.5 | 14.1 | 14.5 | 12.1 | 14.9 | 12.1 |
| Gross profit | 15.6 | 12.0 | 12.6 | 14.3 | 13.7 | 12.8 | 15.5 | 14.9 |
| Gross margin | 55.3% | 47.2% | 50.2% | 50.3% | 48.6% | 51.4% | 51.0% | 55.1% |
| Sales and marketing | 4.7 | 2.8 | 3.2 | 4.3 | 2.9 | 2.5 | | |
| General and administrative | 11.1 | 9.3 | 9.8 | 9.6 | 9.2 | 10.1 | 10.0 | 9.1 |
| EBITA | -0.6 | -0.6 | -0.5 | -0.1 | 1.0 | -0.2 | 2.9 | 2.9 |
| EBITA margin | -2.1% | -2.4% | -1.8% | -0.2% | 3.7% | -0.6% | 9.4% | 10.7% |
| Amortization of intangibles | 0.0 | 0.0 | 0.0 | 0.0 | | | | |
| EBIT | -0.6 | -0.6 | -0.5 | -0.1 | 1.0 | -0.2 | 2.9 | 2.9 |
| EBIT margin | -2.2% | -2.5% | -1.8% | -0.2% | 3.7% | -0.6% | 9.4% | 10.7% |
| Pre-tax income | -0.7 | -0.7 | -0.6 | -0.2 | 0.9 | -0.3 | 2.7 | 2.7 |
| Income taxes | -0.1 | -0.2 | -0.2 | -0.1 | 0.3 | 0.0 | 1.1 | 1.0 |
| Tax rate | 16.4% | 32.1% | 38.7% | 66.1% | 37.4% | | 39.6% | 37.1% |
| Net income | -0.6 | -0.5 | -0.4 | -0.1 | 0.6 | -0.3 | 1.6 | 1.7 |
| Net margin | -2.1% | -2.0% | -1.4% | -0.3% | 2.0% | -1.3% | 5.3% | 6.3% |
| |
| Diluted EPS | ($0.27) | ($0.23) | ($0.16) | $0.00 | $0.02 | ($0.02) | $0.07 | $0.08 |
| Shares outstanding (diluted) | 2.2 | 2.2 | 2.2 | 22.2 | 22.4 | 21.9 | 22.8 | 22.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|